Advertisement
Screener

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) ROA

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) ROA

  • 2026-06-30: ROA 5.84%.
  • 2026-03-31: ROA -0.52%.
  • 2025-12-31: ROA -3.73%.
  • 2025-09-30: ROA -11.95%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-305.84%
2026-03-31-0.52%
2025-12-31-3.73%
2025-09-30-11.95%
2025-06-30-26.46%
2025-03-31-37.70%
2024-12-31-40.14%
2024-09-30-44.71%
2024-06-30-44.69%
2024-03-31-45.43%
2023-12-31-76.79%
2023-09-30-91.44%
2023-06-30-103.16%
2023-03-31-86.24%
2022-12-31-69.32%
2022-09-30-61.06%
2022-06-30-86.54%
2022-03-31-64.44%
2021-12-31-50.56%
2021-09-30-43.69%
2021-06-30-34.72%
2021-03-31-30.48%
2020-12-31-45.49%
2020-09-30-57.67%
2020-06-30-39.00%
2020-03-31-24.90%
2019-12-31-39.24%

Annual ROA

DateROA
2025-12-31-3.73%
2024-12-31-40.14%
2023-12-31-76.79%
2022-12-31-69.32%
2021-12-31-50.56%
2020-12-31-45.49%
2019-12-31-39.24%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59